KOSDAQIT & Software393210

Tomatosystem

₩2,710▼ 0.18%2026-11-18 close
Market Cap
₩42.3B
Turnover
₩1B
Volume
360K
Shares out.
15.6M
PER
29.8×
PBR
1.7×
EPS
₩107
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Profit Turnaround Holds; Cash Flow Is the Next Test

After operating losses in both 2024 and 2025, Tomatosystem posted positive operating profit in each of the first three quarters of 2026, while cash conversion and receivables tied to its U.S. subsidiary remain the next checkpoints.

  1. 1

    Q3 2026 revenue was KRW 8 billion and operating profit was KRW 931 million, a swing from a loss a year earlier on a DART-filed basis.

  2. 2

    Revenue rose 26.1% to KRW 27.3 billion in 2025, yet the company still reported an operating loss of KRW 2.37 billion.

  3. 3

    Operating cash flow turned to a KRW 1.6 billion net outflow in the first half of 2026, and contract assets rose from KRW 3.3 billion to KRW 4.8 billion by end-June, according to press reports based on regulatory filings.

  4. 4

    Loans to the U.S. digital healthcare subsidiary stood at KRW 3.2 billion at end-June 2026 according to press reports, and the company set aside KRW 1.09 billion in bad-debt allowances.

  5. 5

    The order backlog was KRW 23.6 billion at the end of Q1 2026, up 22.9% from a year earlier.

02

Business structure

Tomatosystem is an IT and software company whose two main pillars are university enterprise resource planning (ERP) and its proprietary UI/UX development platform, eXBuilder6.

The company describes its business base as university next-generation information system projects and public and financial-sector projects, built on years of system-integration experience.

According to the independent research house ARIS, the revenue mix on a Q1 2026 consolidated basis was 62.2% solution revenue and 37.8% maintenance and technology revenue.

In the first half of 2026, service revenue reached KRW 6.5 billion, up 52.1% year on year, and solution-in-progress revenue reached KRW 9 billion, up 47.4%, according to a press report based on regulatory filings.

Those two lines accounted for more than 90% of total revenue, while proprietary product revenue of KRW 1.1 billion grew only 4.9%, so the company's own software remains a small share. The customer base is centered on universities.

ARIS estimated that Tomatosystem serves more than 150 of roughly 400 domestic universities, while the company has said it has more than 100 university customers, so the two sources differ.

The UI/UX platform has expanded from universities into private and public customers, including a construction group, a fire insurer and a national health insurance collection system.

The U.S. business centers on the NOVA digital healthcare platform and is being expanded through operating systems for insurance agent management and enrollment portals.

On the AI side, the company is positioning eXBuilder6 AIGen, which combines generative AI with eXBuilder6, as a key second-half focus, while its CEO has said AI sales contribution is still small.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩7B-₩800M−11.0%
2025Q4₩8.8B-₩45,278,365−0.5%
2026Q1₩8.3B₩200M2.9%
2026Q2₩8.4B₩21,406,7090.3%
2026Q3₩8B₩900M11.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩27.1B₩7.5B₩4.6B27.5%36.0%36.1%
2023₩26.6B₩2.8B₩3.3B10.6%11.0%26.0%
2024₩21.6B-₩3.4B-₩1.6B−15.8%−5.7%28.5%
2025₩27.3B-₩2.4B-₩2B−8.7%−7.7%130.9%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On a DART-filed annual basis, revenue was KRW 27.1 billion in 2022, KRW 26.6 billion in 2023 (down 1.9%), KRW 21.6 billion in 2024 (down 18.6%) and KRW 27.3 billion in 2025 (up 26.1%), making 2025 the largest year in the 2022–2025 window.

Operating profit fell from KRW 7.46 billion in 2022 to KRW 2.82 billion in 2023 (down 62.1%), then turned to an operating loss of KRW 3.41 billion in 2024. The 2025 operating loss of KRW 2.37 billion was narrower, but the company has now recorded losses in two consecutive years, 2024 and 2025.

Operating margin moved from 27.5% in 2022 to 10.6% in 2023, -15.8% in 2024 and -8.7% in 2025.

Net profit attributable to controlling shareholders was KRW 4.58 billion in 2022 and KRW 3.29 billion in 2023 (down 28.1%), then turned to a net loss of KRW 1.59 billion in 2024 and widened to a net loss of KRW 2 billion in 2025.

Net income including non-controlling interests, which is a different figure, was a net loss of KRW 1.82 billion in 2024 and KRW 2.78 billion in 2025. Operating cash flow fell from KRW 5.74 billion in 2022 and KRW 4.68 billion in 2023 to a KRW 2.48 billion net outflow in 2024, then recovered to KRW 341 million in 2025.

Quarterly, the company moved from an operating loss of KRW 766 million in Q3 2025 to a loss of KRW 45.28 million in Q4 2025, which was revenue of KRW 8.85 billion, up 26.9% from the prior quarter.

Q1 2026 revenue was KRW 8.28 billion (down 6.4% from the prior quarter) with operating profit of KRW 240 million, a swing to profit. Q2 2026 revenue was KRW 8.42 billion and operating profit was KRW 21.41 million, down 91.1% from the prior quarter.

Q3 2026 revenue was KRW 8 billion, up 14.8% year on year, with operating profit of KRW 931 million, a swing to profit from a year earlier.

Net profit attributable to controlling shareholders was KRW 1.45 billion in Q1 and KRW 668 million in Q3, well above operating profit in those quarters, which suggests non-operating items had a material effect. The last four quarters together add up to KRW 1.63 billion in attributable net profit.

In the first half of 2026, R&D expense fell 80.1% year on year to KRW 400 million, and a press report based on filings noted that revenue growth alone does not explain the swing to operating profit.

05

Industry analysis

ARIS characterizes the university ERP market as entering a 'super cycle' tied to large government education policy. Universities facing shrinking student enrollment are also investing in competitiveness and administrative automation, which could lift demand for replacing legacy systems and building next-generation ERP.

In domestic university ERP, Tomatosystem competes in the same arena as large system integrators, and ARIS cited a 75% re-adoption rate for its eXCampus ERP product as evidence of recurring demand. The company says interest in UI/UX development platforms is rising as digital transformation demand grows.

In generative AI development tools, eXBuilder6 AIGen competes by automatically generating UI screens and source code from natural language and images.

The U.S. digital healthcare business targets Medicare and Medicaid beneficiaries, and according to the 2024 annual report it aims to extend beyond insurers to hospitals and federally qualified health centers.

The company itself describes this business as at an early stage and has disclosed a plan to reach a stable profit structure within five years, so the maturity of the university ERP and healthcare businesses differs sharply.

Compared with large system integrators, the company is small in scale, so whether it wins large projects can drive sizable swings in quarterly results.

06

Outlook

The company said it will focus in the second half of 2026 on its proprietary UI/UX development platform and AI solutions alongside its existing core business. Over the medium to long term, it plans to build its growth base by upgrading AI solutions and commercializing its U.S. digital healthcare business.

On orders, the backlog at Q1 2026 was KRW 23.6 billion, up 22.9% year on year, and according to a Digital Daily report the largest contracts included a KRW 5.69 billion university project, a KRW 3 billion university project and a KRW 2.58 billion construction-sector contract.

ARIS projected 2026 revenue of KRW 32 billion and operating profit of KRW 2 billion in a July 21, 2026 report. This is a third-party estimate, not company guidance.

With press-reported nine-month cumulative revenue of KRW 24.7 billion and operating profit of KRW 1.2 billion, reaching the ARIS figures would require roughly KRW 7.3 billion of revenue and about KRW 800 million of operating profit in Q4.

The company acknowledged that AI solution eXBuilder6 AIGen contributes little revenue so far, while saying public-sector promotion has been active. For the U.S. business, specific indicators such as user counts or paid contract volume have not been disclosed.

The next checkpoints are how close the 2026 annual profit and cash flow in the annual report come to the ARIS estimate, and how AI solution sales appear in the revenue mix.

07

Valuation

PER
29.8×
PBR
1.7×
ROE
6.0%
EPS
₩107
BPS
₩1,825
Dividend per share
₩0

The current earnings multiple is formed on profits that only turned positive in 2026, after losses in 2024 and 2025. Because the earnings base is small, the multiple can move sharply with one-off items in quarterly results. The price-to-book ratio sits above 1x, which means the shares trade above book net asset value.

In 2024 and 2025, losses made an earnings-based multiple impossible to calculate, so earnings-based comparison only became feasible after the 2026 swing to profit. With attributable net profit over the last four quarters totaling KRW 1.63 billion, interpretation of the multiple depends on how quickly earnings build.

Dividend-based comparison carries little meaning for this stock. Compared with large IT services peers such as NAVER and Samsung SDS, the company is far smaller in revenue and earnings, so the same multiple yardstick is hard to apply directly. Multiples are usually read alongside the trend in operating margin and operating cash flow.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Entry into Profitability and Quarterly Improvement

Operating profit was KRW 240 million in Q1 2026 after a swing to profit, then KRW 21.41 million in Q2 and KRW 931 million in Q3, so all three quarters were positive. A Digital Daily report put Q1 revenue growth at 48.3% year on year. IT Daily reported that this was the first operating profit in six quarters since Q2 2024.

University ERP Demand and Order Base

The Q1 2026 order backlog of KRW 23.6 billion rose 22.9% year on year. University contracts such as those with Wonkwang and Seoul National universities sit at the top of the backlog, so university ERP demand forms the order base. ARIS assessed that the university ERP business has entered a super cycle.

Repeat Adoption of Own Platform and Public References

ARIS cited a 75% re-adoption rate for the eXCampus university ERP product and argued that long-accumulated references underpin recurring revenue. IT Daily reported that eXBuilder6 was supplied for a public welfare-system UI, adding public-sector references.

The company's strategy is that the AI solution eXBuilder6 AIGen could widen new demand in the second half of 2026.

09

Bear factors

Volatility in Quarterly Profit

Operating profit in Q2 2026 was KRW 21.41 million, down 91.1% from the prior quarter. Q3 recovered to KRW 931 million, but the quarter-to-quarter swings remain large. Attributable net profit over the last four quarters totals only KRW 1.63 billion, so the earnings base is still thin.

Cash Flow and Contract Asset Burden

Operating cash flow turned to a KRW 1.6 billion net outflow in the first half of 2026. Revenue was recognized as projects progressed, but collections lagged, and contract assets rose from KRW 3.3 billion at end-2025 to KRW 4.8 billion at end-June. Whether operating profit converts into cash inflows remains to be seen.

U.S. Subsidiary Losses and Receivables

According to press reports, the U.S. subsidiary CyberMDCare recorded net losses of KRW 469 million in 2024 and KRW 1.58 billion in 2025. The parent's loan balance stood at KRW 3.2 billion at end-June 2026, and the press reported that receivables of KRW 1.1 billion are also at risk. The company has not disclosed concrete indicators such as user counts or paid contract volume.

10

Risk factors

Overseas Subsidiary Receivables and Bad Debt

Press reports put combined loans and receivables from the U.S. subsidiary above KRW 4 billion at end-June 2026, and the company has set aside KRW 1.09 billion in allowances.

The company has said the business is early-stage and plans to reach a stable profit structure within five years, but it has not disclosed indicators to verify that. Slower collections or additional allowances could weigh on non-operating results and the balance sheet.

Concentration in University Projects

A large share of revenue depends on university ERP and public and financial-sector projects, so quarterly results move with the timing of orders. Service and solution-in-progress revenue made up more than 90% of total revenue in the first half of 2026, which shows the dependence on projects. If large projects slip, quarterly profit could revert to a loss.

Timing of AI Strategy Revenue

The eXBuilder6 AIGen product, positioned as a second-half focus, contributes little revenue so far, as the CEO acknowledged. Proprietary product revenue in the first half of 2026 grew only 4.9% to KRW 1.1 billion.

If generative AI products do not grow enough to change the revenue mix, the limits of labor-intensive SI work may persist.

11

What to watch next

  1. Around March 2027

    Check annual 2026 revenue and operating profit in the annual report. Given nine-month cumulative revenue of KRW 24.7 billion and operating profit of KRW 1.2 billion as reported, the key question is how close Q4 comes to the ARIS estimates of KRW 32 billion and KRW 2 billion.

  2. Around March 2027 (2026 annual report notes)

    Review the balances of related-party loans and receivables from the U.S. subsidiary and any change in bad-debt allowances. Whether collections progress or additional allowances accumulate will shape the balance sheet and non-operating results.

  3. Around May 2027

    Check whether Q1 2027 keeps operating profit positive and whether operating cash flow turns positive. The Q1 2026 operating profit of KRW 240 million and the Q2 2026 figure of KRW 21.41 million can serve as comparison points.

12

Overall view

Tomatosystem's profit structure shifted after operating losses in 2024 and 2025, with operating profit positive in each of the first three quarters of 2026. Annual revenue was largest in 2025 at KRW 27.3 billion, and nine-month cumulative revenue was reported at KRW 24.7 billion.

Supporting factors include university ERP demand, an order backlog of KRW 23.6 billion at Q1 2026, and 48.3% Q1 revenue growth. Offsetting factors include the first-half operating cash outflow, large swings in quarterly profit, and loans and receivables tied to the U.S. subsidiary.

ARIS projected 2026 revenue of KRW 32 billion and operating profit of KRW 2 billion, but that is a third-party estimate rather than a filed figure.

The company presents its AI solutions and digital healthcare as medium- to long-term growth pillars, yet their revenue contribution and user metrics remain limited in disclosure. The next checkpoints are the 2026 annual profit and cash flow in the annual report and the Q1 2027 results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 17 more articles and sources
  1. newspim.com
  2. itdaily.kr
  3. comp.fnguide.com
  4. bloter.net
  5. tomatosystem.co.kr
  6. m.news.nate.com
  7. m.news.nate.com
  8. supple.kr
  9. newspim.com
  10. kind.krx.co.kr
  11. thedailypost.kr
  12. markets.hankyung.com
  13. supple.kr
  14. itdaily.kr
  15. ddaily.co.kr
  16. mt.co.kr
  17. tomatosystem.co.kr

Report written 2026-11-13 · Data as of 2026-11-12

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis